Evidence map›Paper›PMID 34735749›Full record

Observational studyEuropean journal of neurology2022

The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis.

Roberto Bergamaschi, Marta Ponzano, Irene Schiavetti, Luca Carmisciano, Cinzia Cordioli, Massimo Filippi, Marta Radaelli, Paolo Immovilli, Marco Capobianco, Nicola De Rossi and 20 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in European journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 3 countries.

Roberto BergamaschiMultiple Sclerosis Research Center, IRCCS Mondino Foundation, Pavia, Italy.
Marta PonzanoDepartment of Health Sciences, University of Genova, Genova, Italy.ORCID 0000-0003-4091-4686
Irene SchiavettiDepartment of Health Sciences, University of Genova, Genova, Italy.ORCID 0000-0002-5460-2977
Luca CarmiscianoDepartment of Health Sciences, University of Genova, Genova, Italy.ORCID 0000-0001-6263-3864
Cinzia CordioliCentro Sclerosi Multipla ASST Spedali Civili di Brescia, Montichiari, Italy.
Massimo FilippiNeurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0002-5485-0479
Marta RadaelliDepartment of Neurology and Multiple Sclerosis Center, ASST 'Papa Giovanni XXIII', Bergamo, Italy.
Paolo ImmovilliMultiple Sclerosis Center, Ospedale Guglielmo da Saliceto, Piacenza, Italy.
Marco CapobiancoRegional Referral Multiple Sclerosis Centre, Department of Neurology, University Hospital San Luigi, Orbassano (Torino), Italy.ORCID 0000-0003-2501-2932
Nicola De RossiCentro Sclerosi Multipla ASST Spedali Civili di Brescia, Montichiari, Italy.
Giampaolo BrichettoAISM Rehabilitation Center, Italian MS Society, Genoa, Italy.ORCID 0000-0003-2026-3572
Eleonora CoccoCentro Sclerosi Multipla, ATS Sardegna, Cagliari, Italy.
Cinzia ScandellariIRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Riabilitazione Sclerosi Multipla, Bologna, Italy.
Paola CavallaMS Center, Department of Neuroscience, City of Health and Science University Hospital of Turin, Turin, Italy.
Ilaria PesciCentro SM UOC Neurologia, Fidenza, AUSL PR, Fidenza, Italy.
Antonio ZitoMultiple Sclerosis Research Center, IRCCS Mondino Foundation, Pavia, Italy.ORCID 0000-0001-8720-1742
Paolo ConfalonieriMultiple Sclerosis Centre, Neuroimmunology Department 'Carlo Besta' Neurological Institute, Milan, Italy.
Girolama Alessandra MarfiaMultiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, Tor Vergata University, Rome, Italy.
Paola PeriniDepartment of Neurology Multiple Sclerosis Center, University of Padua, Padova, Italy.
Matilde IngleseDepartment of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Maria TrojanoDepartment of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy.
Vincenzo Brescia MorraFederico II University of Naples, Naples, Italy.
Enrico PisoniEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Gioacchino TedeschiDepartment of Advanced Medical and Surgical Sciences, University of Campania, Napoli, Italy.
Giancarlo ComiUniversità Vita Salute San Raffaele, Casa di Cura Privata del Policlinico, Milan, Italy.ORCID 0000-0002-6989-1054
Mario Alberto BattagliaResearch Department, Italian Multiple Sclerosis Foundation, Genoa, Italy.
Francesco PattiDepartment of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Catania, Italy.ORCID 0000-0002-6923-0846
Marco SalvettiDepartment of Neuroscience, Mental Health and Sensory Organs, Sapienza University of Rome, Rome, Italy.
Maria Pia SormaniDepartment of Health Sciences, University of Genova, Genova, Italy.
MuSC-19 study group
University of Genoa · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITOspedale Policlinico San Martino · ITVita-Salute San Raffaele University · ITAssociazione Italiana Sclerosi Multipla · ITCTO Hospital · ITFidal · FRFondazione IRCCS Istituto Neurologico Carlo Besta · ITGuglielmo da Saliceto Hospital · ITIstituto delle Scienze Neurologiche di Bologna · ITIstituto Neurologico Mediterraneo · ITJoint Research Centre · ITOspedale Papa Giovanni XXIII · ITOspedale San Luigi Gonzaga · ITUniversity of Bari Aldo Moro · ITUniversity of Cagliari · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Catania · ITUniversity of Naples Federico II · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeSome studies have shown that air pollution, often assessed by thin particulate matter with diameter below 2.5 µg/m

methodsData were retrieved from an Italian web-based platform (MuSC-19) which includes PwMS with COVID-19. PM2.5 2016-2018 average concentrations were provided by the Copernicus Atmospheric Monitoring Service. Italian patients inserted in the platform from 15 January 2020 to 9 April 2021 with a COVID-19 positive test were included. Ordered logistic regression models were used to study associations between PM2.5 and COVID-19 severity.

resultsIn all, 1087 patients, of whom 13% required hospitalization and 2% were admitted to an intensive care unit or died, were included. Based on the multivariate analysis, higher concentrations of PM2.5 increased the risk of worse COVID-19 course (odds ratio 1.90; p = 0.009).

conclusionsEven if several other factors explain the unfavourable course of COVID-19 in PwMS, the role of air pollutants must be considered and further investigated.

Indexed as

Air PollutionCOVID-19Multiple SclerosisHumansParticulate MatterSARS-CoV-2Particulate Matterair pollutioncoronavirusmultiple sclerosis

Identifiers

PMID34735749
PMCPMC8652772
OpenAlexW3209072451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.